§ Funding Round
Series B funding round for Enveda Biosciences raising $55M in December 2022
Series B funding round for Enveda Biosciences raising $55M in December 2022
| Investor | Firm Type | Partner |
|---|---|---|
Builders VC | — | — |
Business Growth Fund | — | — |
| Organization | — | |
Dimension CapitalLEAD | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Johnson | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Angel | chris gibson | |
| Angel | henry kravis | |
| Angel | jonathan milner | |
| Angel | rajiv chegu | |
| Organization | — | |
| Organization | — | |
| Angel | pegah ebrahimi | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — |
This company has completed 7 funding rounds. Current round is highlighted.
Total Raised
$592M
Top Valuation
-
Enveda Biosciences raised $55M in a Series B round.
The round was announced on 12/01/22.
The round was led by Dimension Capital.
